Business context and reporting period
This is dMY Technology Group, Inc. III’s unaudited Form 10-Q for the quarter ended March 31, 2021—not an IonQ operating-company quarterly report. dMY was a blank-check company that had not commenced operations or generated operating revenue. On March 7, 2021, it agreed to merge with IonQ, Inc. and announced a $350 million PIPE subscription, subject to transaction conditions.
Financial performance and position
- Revenue: No operating revenue; the company’s activities were formation, IPO-related work, and pursuing a business combination.
- Results: Net loss was $2.03 million for the quarter, including $3.82 million of general and administrative expense and $51,531 of franchise tax expense. Trust-account investment income and gains were $46,824. The change in warrant fair value contributed a reported $1.795 million gain. Class B basic and diluted loss per share was $0.27; Class A per-share result was reported as $0.00.
- Cash flow and liquidity: Operating cash use was $1.18 million; cash declined from $1.57 million at year-end 2020 to $386,368 at March 31. The trust account held approximately $300.08 million, largely restricted for a business combination or redemptions. Management reported a $2.9 million working-capital deficiency and concluded available working capital would not cover needs through the earlier of a business combination or one year from filing; this raises substantial liquidity and going-concern concerns.
- Debt and liabilities: Approximately $31,366 remained payable to related parties under a sponsor note; no working-capital loans were outstanding. Total liabilities were $47.75 million, including $10.5 million of deferred underwriting commissions and $33.09 million of warrant liabilities.
- Equity and redemption: Stockholders’ equity was $5.0 million. About 24.85 million Class A shares, carried at $248.51 million, were classified as temporary equity because of possible redemption.
- Margins: Not meaningful because there was no operating revenue.
Material changes versus the prior comparable period
The filing presents a quarter-to-quarter income statement only for 2021, so a prior-year quarterly comparison is not provided. Compared with December 31, 2020, cash fell by about $1.18 million, accrued expenses rose to $3.52 million from $513,000, and warrant liabilities declined to $33.09 million from $34.89 million. Shares classified as subject to possible redemption decreased by about 203,000.
Outlook, risks, contingencies, and unusual items
- The proposed IonQ merger and $350 million PIPE were announced, but completion was not assured. The SPAC’s business-combination deadline was November 17, 2022; failure to complete a combination would trigger liquidation and redemption provisions.
- Warrants were classified as derivative liabilities and remeasured at fair value, creating potentially material noncash earnings volatility. The filing describes a material weakness in internal controls related to warrant accounting; controls and procedures were concluded to be ineffective, and remediation was ongoing without assurance of success.
- The filing says previously issued financial statements were restated following SEC staff guidance on SPAC warrant accounting. It warns of possible future litigation or disputes related to the restatement and control weakness.
- A lawsuit involving the sponsor and others included counterclaims naming the company and certain associated parties; the company denied the claims and said it would defend them. The filing’s “Legal Proceedings” item separately states “None,” an apparent inconsistency to review.
- COVID-19-related uncertainty could affect the company’s ability to complete a business combination. Potential transaction financing through additional equity or debt could dilute shareholders or increase leverage.
Investor verification priorities
- Confirm the transaction’s status and terms: this filing reports a proposed merger and PIPE, not completed IonQ operating results.
- Review the going-concern disclosure, cash available outside the trust, and any sponsor or other financing commitments.
- Check the warrant-accounting restatement, valuation effects, and progress in remediating the material weakness.
- Reconcile the lawsuit disclosure with the statement that there were no legal proceedings.
- Verify administrative-service expense: the notes report $30,000 for the quarter, while MD&A reports $50,000.